In prior studies of lung adenocarcinoma, we identified a circulating protein signature that reflected activation at early stages of Titf1/Nkx2-1, a known lineage-survival oncogene in lung cancer. This evidence concerns the gene NKX2-1 and lung adenocarcinoma.